0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 17 results.
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign...
Catalog:
RNCOS
June 2022
Price: USD 900.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy’s Laboratories is an India based multinational...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceutical market was the 11 th largest pharmaceuticals market by value in the world in 2017. It is expected to register second highest...
Catalog:
NAVADHI
April 2019
Price: USD 3,500.00
Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
India is expected to witness a remarkable rise in healthcare infrastructure in upcoming years. There will there be a dramatic rise in the type and...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
